Quick Takeaways
- Woodline Partners LP filed SCHEDULE 13G/A for PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX).
- Disclosed ownership: 3.3%.
- Date of event: 31 Dec 2025.
Woodline Partners LP - 31 Dec 2025 SCHEDULE 13G/A Report for PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX)
- Filing Manager
- Woodline Partners LP
- Reporting Manager
- Woodline Partners LP
- Symbol
- PLRX
- Shares outstanding
- 61,399,727 shares
- Disclosed Ownership
- 2,026,191 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 15:21:41 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Woodline Partners LP disclosed 3.3% ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 15:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Woodline Partners LP | 3.3% | 2,026,191 | 2,026,191 | 0 | /s/ Erin Mullen | Erin Mullen, General Counsel & Chief Compliance Officer |